MoneyWorks4Me

Lupin’s FY13 consolidated net soars by 51%

08 May 2013 Evaluate

Lupin has reported results for the year ended March 31, 2013.

For the year, the company’s net profit grew by 56.70% at Rs 1260.43 crore as compared to Rs 804.37 crore for the year ended March 31, 2012. Its total income has increased by 32.61% to Rs 7145.82 crore for the year from Rs 5388.32 crore for the previous year.

On consolidated basis, the group’s net profit after taxes, minority interest stood at Rs 1314.16 crore for the FY13 as compared to Rs 867.65 crore in FY12, up by 51.46%. Groups’s total income has increased by 36.24% to Rs 9669.15 crore for the year under review from Rs 7097.26 crore for the previous year.

Lupin’s board of directors at its meeting held on May 08, 2013, inter alia, has recommended dividend at the rate of 200% i.e. Rs 4 per equity shares of the face value of Rs 2 each for the year ended March 31, 2013.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..